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Abstract 
Purpose: To report a case series of two cases of granulomatosis with polyangiitis, previously known as 
Wegener granulomatosis, which developed macular necrosis, not previously associated with 
granulomatosis with polyangiitis, healed with fibrosis, despite aggressive immune-modulating therapy 
and good control of systemic disease. 
Methods: Case series of two cases with observation of treatment progress. 
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Results: The results reported the progress of response to treatment in the two cases, which resulted in the 
final outcome of fibrosis in the macula region, despite being on aggressive immune-modulating therapy 
and good systemic control. 
Conclusion: Granulomatosis with polyangiitis can be associated with macular necrosis leading to fibrosis, 
unresponsive to immune-modulating therapy. 
A significant proportion of granulomatosis with polyangiitis (GPA), previously known as Wegener 
granulomatosis, cases are associated with ocular complications, mainly orbital inflammation, peripheral 
keratitis, and scleritis. Less common ocular complications include retinitis, uveitis, retinal vascular 
occlusions, and exudative retinal detachment. We report a case series of two cases of GPA, which 
developed macular necrosis, not previously associated with GPA, healed with fibrosis, despite aggressive 
immune-modulating therapy (IMT) and good control of systemic disease. 
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Materials and Methods 
Case Series 
Case 1 
A 53-year-old white woman was diagnosed with GPA based on pulmonary mass lesion, hematuria, and 
elevated quantitative serum anti-proteinase 3 antibodies (cANCA) of 80 U/mL (normal < 2.4 U/mL). She 
was started on oral cyclophosphamide and prednisone, which resulted in resolution of the pulmonary 
mass lesion and hematuria. However, she developed painless visual loss in her left eye over 1 month with 
presenting visual acuity of counting fingers at 1 foot. The right eye was unaffected. Ocular examination of 
left eye revealed fine keratic precipitates in the cornea, with 1+ cells in the anterior chamber and 1+ 
vitreous cells, and an elevated yellowish macular lesion (Figure 1). 
Case 2 
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A 46-year-old white man was referred to the ophthalmology department by the inpatient neurology 
service. He had a 1-month history of a gradual and profound visual loss in the right eye, with a recent 
onset of visual disturbance in the left a few days before referral. He had been otherwise healthy until 18 
months before the onset of visual symptoms when he developed multiple upper respiratory problems and 
sequential neurologic deficits, separated in time by several months, including frequent rhinitis, followed 
by otitis media with hearing loss, numerous nose bleeds, Bell's palsy, difficulty with balance, recurrent 
Bell's palsy, and finally, weakness and numbness of his left foot. Just before presentation, he developed 
left upper eyelid ptosis and left forehead numbness. He had lost 30 pounds over the course of the previous 
year despite having been on and off oral prednisone for the last 6 months. 
On initial examination, his visual acuity was 20/200 right eye and 20/25 left eye, with a right relative 
afferent pupillary defect. He had ptosis on the left and was noted to have a saddle nose deformity. Dilated 
fundus examination revealed 0.5+ vitreous cells on the right, with a large subretinal lesion involving the 
entire macula with partial extension to the mid-periphery and a small exudative retinal detachment 
inferiorly. The left posterior pole showed 3 foci similar appearing white subretinal lesions (Figure 3). 
Results 
Case 1 
Fundus fluorescein angiography showed capillary nonperfusion and retinal vascular leakage compatible 
with occlusive retinal vasculitis within the lesion. Owing to the striking clinical appearance, an 
opportunistic fungal was suspected. Cyclophosphamide was stopped and systemic amphotericin B was 
begun. Serologic testing for IgG and IgM antibodies against Toxoplasma gondii, Toxocara spp, 
Histoplasma capsulatum, Aspergillus spp, Candida spp, and Coccidioides immitis was negative. Over the 
next 10 days, despite systemic antifungal therapy, the lesion enlarged. The patient underwent immediate 
diagnostic pars plana vitrectomy, subretinal aspiration and biopsy, and intravitreal injections of 
amphotericin B 5 µg, vancomycin 1 mg, amikacin 400 µg, and clindamycin 300 µg. No intraocular 
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corticosteroids were given. Histopathologic evaluation, including Gram and Giemsa stains, of the 
biopsied material from the vitreous, subretinal space, and retina revealed macrophages, lymphocytes, and 
neutrophils with no evidence of fungi, bacteria, or protozoa. Polymerase chain reaction for toxoplasmosis, 
HSV, HSV2, and VZV and fungal and bacterial cultures were negative. The prednisone dosage was 
increased postoperatively to 60 mg daily and tapered over 3 months. One month after surgery, the patient 
developed a rhegmatogenous retinal detachment from a break at the posterior macular biopsy site with 
early proliferative vitreo-retinopathy requiring pars plana vitrectomy, scleral buckle, and silicone oil 
tamponade. The macular lesion became fibrotic with 3 months of the first surgery (Figure 2). Over the 
next 12 months, the patient received a cumulative dose of 27 grams of cyclophosphamide after which she 
was switched to azathioprine for 5 years and is now maintained on methotrexate with complete remission 
of GPA. 
Case 2 
The patient underwent magnetic resonance imaging, which revealed enlargement of the left lateral and 
superior rectus muscles, extensive sinus disease, and pachymeningitis. Biopsy of the left orbit revealed a 
lymphoplasmacytic infiltrate, focal chronic vasculitis with vessel wall disruption (Figure 4), and no 
evidence of monoclonality or lymphoma on flow cytometry or cytology. No fungal or bacterial elements 
were seen or present on culture. 
The patient was started on 60 mg of prednisone effecting a dramatic improvement in the appearance of 
the subretinal lesions within 3 weeks (Figure 5).  
Although the patient's cANCA was originally negative, the positive myeloperoxidase antibody together 
with the clinical features, pathologic findings, and response to therapy modified our final diagnostic 
impression to that of myeloperoxidase ANCA positive GPA. After rheumatologic consultation, the 
patient started on oral cyclophosphamide with a slow prednisone taper, pneumocystis prophylaxis, and 
has continued to improve. The subretinal lesions were noted to resolve with overlying retinal pigment 
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epithelial disturbances with a best-corrected visual acuity of 20/200 (right eye) and 20/20 (left eye) at his 
last follow-up visit. 
Discussion 
Ocular complications, mainly peripheral keratitis and scleritis, occur in 30%–60% of GPA cases.1–3 
Retinal vasculitis in GPA is uncommon and responds to IMT.4,5 Our patient unfortunately developed 
unilateral macular granuloma, not previously reported to be associated with GPA, which progressed to 
macular fibrosis despite aggressive IMT and good control of systemic disease. The reasons as to why the 
vasculitic process leading to macular necrosis was not responsive to IMT remained unclear. However, this 
complication was not previously reported in GPA, and the treating clinician should accord intensive IMT 
treatment to patients with GPA who demonstrate any inflammatory ocular problems. In conclusion, GPA 
can be associated with macular necrosis leading to fibrosis, unresponsive to IMT. 
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Figures 
Fig. 1. Case 1, maculopathy at presentation. 
 
  
8 
Fig. 2. Case 1, the fibrotic macula post treatment. 
 
Fig. 3. Case 2, bilateral fundus at presentation. 
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Fig. 4. Case 2, histology showing granulomatosis polyangiitis. 
 
Fig. 5. Case 2, right and left fundus photographs, 22 days after beginning steroids. 
 
